Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses (Q24244015)

title

Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

12 May 2020

R B Belgamwar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

12 May 2020

M Fenton

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

Cochrane Database of Systematic Reviews

12 May 2020

publication date

20 April 2005

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

12 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

12 May 2020

page(s)

CD003729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Emergency psychiatry: contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Radioreceptor binding profile of the atypical antipsychotic olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

A description of agitation in a nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Characteristics of violent behaviour in acute psychiatric in-patients: a 5-year Italian study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Haloperidol plus promethazine for psychosis-induced aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Acute psychopharmacological management of the aggressive psychotic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Neuroleptic malignant syndrome associated with olanzapine therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Droperidol versus haloperidol for chemical restraint of agitated and combative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003729.PUB2

Dopamine receptor pharmacology

21 January 2018

1 reference

12 December 2020

Development of a scale for assessment of agitation following traumatic brain injury

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review

1 reference

12 December 2020

The Expert Consensus Guideline Series. Treatment of behavioral emergencies

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics

1 reference

12 December 2020

A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms

1 reference

12 December 2020

Neuroleptic malignant syndrome associated with olanzapine

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1 reference

12 December 2020

10.1002/14651858.CD003729.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

65812

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

12 May 2020

65812

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json

12 May 2020

PubMed publication ID

15846678

2 references

Consolidated OpenCitations Corpus – April 2017

65812

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6769079&resulttype=core&format=json